Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

QUEST DIAGNOSTICS INC Earnings Release 2012

Apr 18, 2012

30275_rns_2012-04-18_c149d30a-4486-464e-8b93-ff28fac01254.zip

Earnings Release

Open in viewer

Opens in your device viewer

| UNITED
STATES |
| --- |
| SECURITIES
AND EXCHANGE COMMISSION |
| WASHINGTON,
DC 20549 |
| FORM 8-K |
| CURRENT
REPORT PURSUANT TO SECTION 13 OR 15(d) OF |
| THE
SECURITIES EXCHANGE ACT OF 1934 |
| Date of Report (Date
of Earliest Event Reported) : April 18, 2012 |
| Quest
Diagnostics Incorporated |
| (Exact Name of
Registrant as Specified in Its Charter) |
| Delaware |
| (State or other
jurisdiction of incorporation) |

001-12215 16-1387862
(Commission File
Number) (I.R.S. Employer
Identification No.)
Three Giralda Farms
Madison, NJ 07940
(Address of principal
executive offices) (Zip Code)
(973) 520-2700
(Registrant’s telephone
number, including area code)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the
registrant under any of the following provisions ( see General
Instruction A.2. below):

| o | Written communications pursuant to Rule 425 under
the Securities Act (17 CFR 230.425) |
| --- | --- |
| o | Soliciting material pursuant to Rule 14a-12 under
the Exchange Act (17 CFR 240.14a-12) |
| o | Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| o | Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |

Item 2.02. Results of Operations and Financial Condition

On April 18, 2012 Quest Diagnostics Incorporated (the “Company”) issued a press release announcing, among other things, its results for the quarter ended March 31, 2012. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein.

Item 9.01. Financial Statements and Exhibits

d.
99.1 Press release of Quest Diagnostics Incorporated
dated April 18, 2012, announcing, among other things, its results for the
quarter ended March 31, 2012.

Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

April 18, 2012

Robert A. Hagemann
Robert A. Hagemann
Senior Vice President and Chief Financial Officer